Calcium-enriched bread for treatment of uremic hyperphosphatemia

Journal of Renal Nutrition

Volumn 14, Issue 3, 2004, Pages 149-156

  Babarykin, Dmitry ^a   Adamsone, Inara ^a   Amerika, Diana ^a   Spudass, Aldis ^a   Moisejev, Vladimir ^b   Berzina, Nadezhda ^b   Michule, Linda ^a   Rozental, Rafail ^a  

^a RIGA STRADINS UNIVERSITY   (Latvia)

^b UNIVERSITY OF LATVIA   (Latvia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CALCIUM ACETATE; PHOSPHATE; PHOSPHATE BINDING AGENT;

ADULT; ARTICLE; BREAD; CALCIUM BLOOD LEVEL; CALCIUM INTAKE; CONTROLLED STUDY; DIET THERAPY; FEMALE; HEMODIALYSIS; HUMAN; HYPERPHOSPHATEMIA; MAJOR CLINICAL STUDY; MALE; PHOSPHATE BLOOD LEVEL; TREATMENT OUTCOME; UREMIA;

ACETATES; BREAD; CALCIUM; CALCIUM, DIETARY; DIET RECORDS; FEMALE; FOOD, FORTIFIED; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PHOSPHATES; PHOSPHORUS, DIETARY; RENAL DIALYSIS; UREMIA;

TRITICUM AESTIVUM;

EID: 3042548096     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2004.04.004     Document Type: Article

References (14)

1. Rozental R.L., Babarykin D.A., Tikhomirova T.E., et al. Renal osteodystrophy and its possible correction in patients on chronic hemodialysis. Ter Arkh. 58:1986;105-108
2. Llach F. Hyperphosphatemia in end-stage renal disease patients Pathophysiological consequences. Kidney Int. 56:(suppl 73):1999;S31-S37
3. Drueke T.B. Renal osteodystrophy Management of hyperphosphataemia. Nephrol Dial Transplant. 15:(suppl 5):2000;32-33
4. Babarykin D.A., Afanaseva G.A., Shulman O.M., et al. Treatment of hyperphosphatemia in chronic renal failure. Ter Arkh. 56:1984;64-66
5. Hutchison A.J. Calcitriol, lanthanum carbonate, and other new phosphate binders in the management of renal osteodystrophy. Perit Dial Int. 19:(suppl 2):1999;S408-S412
6. Gallieni M., Cozzolino M., Carpani P., et al. Sevelamer reduces calcium load and maintains a low calcium-phosphorus ion product in dialysis patients. J Nephrol. 14:2001;176-183
7. 7 A21D 8/02
8. Van den Bergh J.P., Gelens M.A., Klaassen H.A., et al. Efficacy and tolerance of three different calcium acetate formulations in hemodialysis patients. Neth J Med. 55:1999;222-228
9. Takahashi N., Shoji T., Matsubara K., et al. Effect of histamine H2-receptor antagonist on the phosphorus-binding abilities of calcium carbonate and calcium lactate in hemodialysis patients. J Am Soc Nephrol. 10:1999;1090-1094
10. Dunstan C.R., Eade Y.L., Evans M., et al. The effectiveness of a soluble calcium preparation as a gut phosphate binder. Metabolism. 37:1988;815-819
11. McIntyre C.W., Patel V., Taylor G.S., et al. A prospective study of combination therapy for hyperphosphataemia with calcium-containing phosphate binders and sevelamer in hypercalcaemic haemodialysis patients. Nephrol Dial Transplant. 17:2002;1643-1648
12. Slatopolsky E., Finch J., Denda M., et al. Phosphorus restriction prevents parathyroid gland growth High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest. 97:1996;2534-2540
13. Naveh-Many T., Rahamimo R., Livni N., et al. Parathyroid cell proliferation in normal and chronic renal failure rats The effects of calcium, phosphate and vitamin D. J Clin Invest. 96:1995;1786-1793
14. Takahashi F., Finch J., Brown A.J., et al. The effects of a low phosphorus diet on the section of PTH in establishing diffuse parathyroid hyperplasia. J Am Soc Nephrol. 8:1997;508A. (abstr)